BACKGROUND: Experimental studies suggest that endothelial growth factors play an important role in angiogenesis and vascular remodeling. The clinical and genetic correlates of circulating angiopoietin-2 (Ang-2) and its soluble receptor/regulator Tie-2 (sTie-2) have not been determined in a community-based sample. METHODS AND RESULTS: Serum Ang-2 and sTie-2 were assayed in 3778 third-generation cohort participants of the Framingham Heart Study (mean age, 40+/-9 years; 53% women). Clinical correlates and heritability of both biomarkers were assessed using generalized estimating equations and variance-component analyses. Ang-2 levels were higher and sTie-2 levels were lower in women than in men. Ang-2 was positively related to age, smoking, systolic blood pressure, hypertension treatment, and diabetes (P<0.05 for all) but was inversely associated with total cholesterol and diastolic blood pressure (P<0.0001 for both), and sTie-2 was positively associated with body mass index, diabetes, and triglycerides but was inversely related to age, alcohol consumption, and glomerular filtration rate (P<0.05 for all). Both Ang-2 and sTie-2 were higher in participants with metabolic syndrome (P<0.005), with stronger associations of Ang-2 with blood pressure traits and of sTie-2 with obesity-dyslipidemia components. Heritability estimates for Ang-2 and sTie-2 were 27% and 56%, respectively (P<0.0001). A region on chromosome 9 was significantly linked to circulating sTie-2 levels (logarithm of the odds score, 8.31). CONCLUSION: Circulating levels of Ang-2 and sTie-2 are heritable traits associated with cardiovascular disease risk factors, including the metabolic syndrome. These observations are consistent with the notion that angiogenesis and vascular remodeling are determined in part by genetic influences and associated with metabolic risk factors.
BACKGROUND: Experimental studies suggest that endothelial growth factors play an important role in angiogenesis and vascular remodeling. The clinical and genetic correlates of circulating angiopoietin-2 (Ang-2) and its soluble receptor/regulator Tie-2 (sTie-2) have not been determined in a community-based sample. METHODS AND RESULTS: Serum Ang-2 and sTie-2 were assayed in 3778 third-generation cohort participants of the Framingham Heart Study (mean age, 40+/-9 years; 53% women). Clinical correlates and heritability of both biomarkers were assessed using generalized estimating equations and variance-component analyses. Ang-2 levels were higher and sTie-2 levels were lower in women than in men. Ang-2 was positively related to age, smoking, systolic blood pressure, hypertension treatment, and diabetes (P<0.05 for all) but was inversely associated with total cholesterol and diastolic blood pressure (P<0.0001 for both), and sTie-2 was positively associated with body mass index, diabetes, and triglycerides but was inversely related to age, alcohol consumption, and glomerular filtration rate (P<0.05 for all). Both Ang-2 and sTie-2 were higher in participants with metabolic syndrome (P<0.005), with stronger associations of Ang-2 with blood pressure traits and of sTie-2 with obesity-dyslipidemia components. Heritability estimates for Ang-2 and sTie-2 were 27% and 56%, respectively (P<0.0001). A region on chromosome 9 was significantly linked to circulating sTie-2 levels (logarithm of the odds score, 8.31). CONCLUSION: Circulating levels of Ang-2 and sTie-2 are heritable traits associated with cardiovascular disease risk factors, including the metabolic syndrome. These observations are consistent with the notion that angiogenesis and vascular remodeling are determined in part by genetic influences and associated with metabolic risk factors.
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin Journal: Nature Date: 1995-07-06 Impact factor: 49.962
Authors: Agnieszka A Ardelt; Louise D McCullough; Kenneth S Korach; Michael M Wang; Diane H Munzenmaier; Patricia D Hurn Journal: Stroke Date: 2005-01-06 Impact factor: 7.914
Authors: T Asahara; D Chen; T Takahashi; K Fujikawa; M Kearney; M Magner; G D Yancopoulos; J M Isner Journal: Circ Res Date: 1998-08-10 Impact factor: 17.367
Authors: Justin P Zachariah; Vanessa Xanthakis; Martin G Larson; Joseph A Vita; Lisa M Sullivan; Holly M Smith; Radwan Safa; Xuyang Peng; Naomi Hamburg; Daniel Levy; Douglas B Sawyer; Gary F Mitchell; Ramachandran S Vasan Journal: Hypertension Date: 2012-02-27 Impact factor: 10.190
Authors: Heming Wang; Brian E Cade; Han Chen; Kevin J Gleason; Richa Saxena; Tao Feng; Emma K Larkin; Ramachandran S Vasan; Honghuang Lin; Sanjay R Patel; Russell P Tracy; Yongmei Liu; Daniel J Gottlieb; Jennifer E Below; Craig L Hanis; Lauren E Petty; Shamil R Sunyaev; Alexis C Frazier-Wood; Jerome I Rotter; Wendy Post; Xihong Lin; Susan Redline; Xiaofeng Zhu Journal: Hum Mol Genet Date: 2016-12-01 Impact factor: 6.150
Authors: Reiner A Wimmer; Alexandra Leopoldi; Martin Aichinger; Nikolaus Wick; Brigitte Hantusch; Maria Novatchkova; Jasmin Taubenschmid; Monika Hämmerle; Christopher Esk; Joshua A Bagley; Dominik Lindenhofer; Guibin Chen; Manfred Boehm; Chukwuma A Agu; Fengtang Yang; Beiyuan Fu; Johannes Zuber; Juergen A Knoblich; Dontscho Kerjaschki; Josef M Penninger Journal: Nature Date: 2019-01-16 Impact factor: 49.962
Authors: Wolfgang Lieb; Ming-Huei Chen; Martin G Larson; Radwan Safa; Alexander Teumer; Sebastian E Baumeister; Honghuang Lin; Holly M Smith; Manja Koch; Roberto Lorbeer; Uwe Völker; Matthias Nauck; Henry Völzke; Henri Wallaschofski; Douglas B Sawyer; Ramachandran S Vasan Journal: Circ Cardiovasc Genet Date: 2014-12-31
Authors: Jessica L Montoya; Jennifer Iudicello; Pariya L Fazeli; Suzi Hong; Michael Potter; Ronald J Ellis; Igor Grant; Scott L Letendre; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2017-02-01 Impact factor: 3.731
Authors: Klara J Rosenquist; Joseph M Massaro; Alison Pedley; Michelle T Long; Bernard E Kreger; Ramachandran S Vasan; Joanne M Murabito; Udo Hoffmann; Caroline S Fox Journal: J Clin Endocrinol Metab Date: 2015-01 Impact factor: 5.958